PLEASANTON, Calif. – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced publication of two-year results from the 206-patient L.I.F.T. IDE Study, a multi-center, randomized, blinded study of the novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH).
The study, published in Urology Practice, an official journal of The American Urological Association, concluded that the UroLift System preserves sexual function and provides rapid improvement in symptoms, … Continue reading NeoTract, Inc. Announces Publication Showing Sustained Safety and Efficacy Benefits for the Minimally Invasive UroLift® System Treatment for Enlarged Prostate